Navigation Links
Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
Date:2/12/2013

SCOTTSDALE, Ariz., February 12, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company focused on prescription Medical Foods, today announced that Danilo Casadei Massari , the founder of CM&D Pharma recently acquired by Nestle, has joined Prismic's Management Team and Board of Directors.

Casadei Massari, who has an outstanding reputation as a successful healthcare entrepreneur, becomes President Europe with additional responsibility for worldwide corporate development. He has also been elected to the company's Board of Directors.

Commenting on this significant development, Peter Moriarty , CEO and Chairman of the Board of Directors, stated, "Danilo has been involved in the founding and development of a number of very successful companies in the pharmaceutical and healthcare arenas. His venture prior to Prismic was CM&D Pharma, a European-based company also focused on prescription Medical Foods. CM&D Pharma was the first acquisition made by Nestle Health Science, a company established by Nestle in 2011 to create a new market between Food and Pharmaceuticals."

Danilo Casadei Massari added that "Prismic is developing an extremely interesting portfolio. These are all IP protected, science-based products that are safe and effective, and can be expeditiously brought to market as prescription Medical Foods. One or two of these are also being evaluated as potential NDA candidates based on clinical data we have seen so far. Our focus is on products that can cost-effectively address commonly occurring disorders in the aging "baby boomer" population, and especially those where inflammation is an underlying cause."

In summing-up, Peter Moriarty stated, "This is another major step-forward for Prismic, especially as we have also recently completed our initial round of equity funding which was significantly over-subscribed."

About Prismic Pharmaceuticals, Inc. Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved. The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com 

INFORMATION CONTACT Peter Moriarty Tel : 480.422.1810


'/>"/>
SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
2. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
3. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
4. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
5. Vibrant Research Founder Dr. Pratheev Sreetharan Recipient of the TR35 Award from Technology Review Magazine
6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
7. Microsofts Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dows Loss Yesterday
8. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
9. Hemp, Inc.s CEO, Bruce Perlowin, to Speak at Hempcon 2013 Tour on "Hemp and Medical Marijuana Public Company Stocks" and the "Industrial Hemp Industry"
10. Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Companys Growth and International Expansion Plan
11. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... addition of the  "Global Anesthesia Disposables Market ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ,The global anesthesia ... a CAGR of 4.03% during the period ... a major threat to patients, safety. Organizations ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... expected to reach USD 2.06 billion by 2022, ... Research, Inc. Increasing consumer awareness towards a healthy ... the next seven years.      (Logo: ... diet intake coupled with rising health treatment expenditure ...
(Date:4/26/2016)... 2016 Hill-Rom Holdings, Inc. (NYSE: HRC ... the Deutsche Bank 41 st Annual Health Care Conference ... You are invited to listen to the live discussion ... it directly at http://edge.media-server.com/m/p/mr4uxgas . A recorded replay of ... the live event and accessible at the links above until ...
Breaking Medicine Technology:
(Date:4/29/2016)... Los Angeles, CA (PRWEB) , ... April 29, 2016 , ... ... Sarah Mirmelli, a mother and divorcee, shares her enthusiasm for Botox and lip injections, ... of the world famous youth oriented Coachella Valley Music and Arts Festival. The article ...
(Date:4/29/2016)... Fl (PRWEB) , ... April 29, 2016 , ... ... recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that it ... , This is the first accreditation of three residency programs that Memorial is ...
(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... our nation’s productivity, stability, even security. Most importantly, employees are the single most ... why are American workers so unhappy? , Just under half of American workers ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White ... repaying their loans, more information about their loan terms and accounts, and more ... loan debt, including federal and private loans, has reached $1.3 trillion, with 43 ...
Breaking Medicine News(10 mins):